ENTREVESTOR: After 15 months on TSX Venture, Appili’s market cap has grown to $65.9 million.

Appili Therapeutics Inc.’s common shares will begin trading on the main board of the Toronto Stock Exchange on Wednesday, after spending 15 months on the TSX Venture exchange.

The Halifax-based company, which is working on bringing a portfolio of anti-infectious drugs to market, issued a statement Monday saying the change would take place at the start of trading Wednesday. By trading on the main TSX board, the company will have exposure to a broader group of investors, which should make it easier to raise capital.